SEI Investments’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
RG
VCM
DCM
ES
SEI Investments's IMNM Position: Q1 2026 in Review
SEI Investments increased its Immunome (IMNM) stake by 90% in Q1 2026, buying an estimated $558K and bringing the position to 52,770 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2290.
SEI Investments first reported a position in IMNM in Q1 2024 and has held it in 5 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.
- SEI Investments held 52,770 shares of Immunome worth $1.15M as of Q1 2026.
- SEI Investments bought 25,051 Immunome shares in Q1 2026, an estimated $558K.
- Immunome made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2290 holding.
- SEI Investments first reported a position in Immunome in Q1 2024 and has held it in 5 quarters since.
- 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.